Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

Causes of Dizziness in Patients Taking Beta Blockers

Primary Mechanisms of Beta Blocker-Induced Dizziness

  • The American Heart Association notes that beta blockers slow heart rate and cardiac conduction, which is generally asymptomatic but can cause dizziness or lightheadedness when significant 1
  • Beta blockers, especially those with alpha-1-receptor blocking properties, can produce hypotension leading to dizziness, lightheadedness, or blurred vision 1

Risk Factors for Beta Blocker-Induced Dizziness

  • Patients with pre-existing conduction abnormalities are at increased risk for bradycardia-related dizziness, according to the American College of Cardiology 2
  • Elderly patients are more susceptible to bradycardia, conduction disorders, and hypotensive effects of beta blockers 3
  • Concurrent medications that can cause bradycardia or heart block may exacerbate dizziness when combined with beta blockers, as reported by the American Heart Association 1, 2
  • Volume depletion increases the risk of hypotension and associated dizziness in patients taking beta blockers 1

Management of Beta Blocker-Induced Dizziness

  • For bradycardia-induced dizziness, the American Heart Association recommends decreasing the dose of the beta blocker if bradycardia is accompanied by dizziness or lightheadedness 1, 2
  • For hypotension-induced dizziness, consider administering beta blocker and ACE inhibitor at different times of day, or temporary reduction in diuretic dose in volume-depleted patients, as suggested by the American Heart Association 1
  • If hypotension is accompanied by other clinical evidence of hypoperfusion, beta blocker therapy should be decreased or discontinued pending further evaluation, according to the American Heart Association 1

Important Considerations

  • Abrupt withdrawal of beta blockers can lead to clinical deterioration and should be avoided, particularly in patients with coronary artery disease, as warned by the American Heart Association 1
  • Consider switching to a beta-1 selective agent if dizziness is problematic, as these have fewer peripheral vascular effects, recommends the American College of Cardiology 2, 4

Monitoring and Follow-up

  • Regular monitoring of vital signs, including heart rate and blood pressure, is necessary to detect significant bradycardia or hypotension, as advised by the American College of Cardiology 2
  • Monitor PR interval in patients with first-degree AV block, especially if greater than 300 ms, recommends the American College of Cardiology 2
  • Assess for presence of dizziness, lightheadedness, and signs of hypoperfusion, as suggested by the American College of Cardiology 2